Related Experiment Videos
Molecular basis of allergic diseases
1Division of Pediatric Allergy and Immunology, National Jewish Medical and Research Center, Denver, Colorado 80206, USA. leungd@njc.org
Molecular Genetics and Metabolism
|June 3, 1998
Summary
This review details allergic disease mechanisms, highlighting immunoglobulin E (IgE) and T helper 2 (TH2) cells. Understanding these pathways is key for developing new allergy treatments.
Area of Science:
- Immunology
- Allergy Research
Background:
- Allergic diseases involve complex immune responses.
- Immunoglobulin E (IgE) and its receptor mediate immediate hypersensitivity.
- Late-phase responses are characterized by eosinophils and T lymphocytes.
Purpose of the Study:
- To review current understanding of allergic disease mechanisms.
- To identify key cells and molecules in allergic inflammation.
- To explore potential therapeutic targets for allergic illnesses.
Main Methods:
- Literature review of immunological mechanisms in allergic diseases.
- Analysis of the roles of IgE, mast cells, T cells, and cytokines.
- Examination of factors influencing disease progression and treatment response.
Main Results:
- IgE binding to high-affinity receptors on mast cells triggers mediator release.
- Helper type 2 (TH2) cytokines (IL-4, IL-5, IL-13) drive IgE synthesis and eosinophil development.
- Early immune activation failure impacts glucocorticoid therapy and disease progression.
Conclusions:
- Key cells and molecules in allergic inflammation are crucial therapeutic targets.
- Targeting IgE, TH2 cytokines, and immune activation pathways may treat allergic diseases.
- Further research into these mechanisms can lead to novel allergy treatments.